Search - tctmd.com

Displaying 21 - 40 of 103

Sort: Relevancy | Date

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

News Conference News ESC 2024

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

Yael L. Maxwell

August 31, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF

Todd Neale

September 01, 2023

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

Presentation ESC 2023

The HEART-FID Trial: Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency

Presenter: Robert Mentz

August 28, 2023

Presentation ESC 2023

The Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial

Presenter: Jozine M. ter Maaten

August 28, 2023

Presentation ESC 2023

DICTATE AHF: Efficacy and Safety of Dapagliflozin in Acute Heart Failure

Presenter: Zachary Cox

August 28, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Conference News ESC 2023

IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role

Shelley Wood

August 26, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death

Todd Neale

September 02, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

Presentation ESC 2022

Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial

Presenter: Otavio Berwanger

August 29, 2022

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Shelley Wood

August 27, 2022

News Conference News ESC 2022

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

Todd Neale

August 27, 2022

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

L.A. McKeown

August 27, 2022

Advertisement

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

The HEART-FID Trial: Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency

The Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial

DICTATE AHF: Efficacy and Safety of Dapagliflozin in Acute Heart Failure

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

CV Care Around Noncardiac Surgery: New ESC Guidelines

ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content